Given that both HuR and telomerase promote human cancer and cell growth, and that they both inhibit aging, cell senescence, and apoptosis24–29,36,37, we propose that the HuR-telomerase regulatory paradigm is a major component of these processes. This evidence concerns the gene ELAVL1 and cancer.